» Articles » PMID: 1599053

Effect of Different Fractions of Heparin on Plasmodium Falciparum Merozoite Invasion of Red Blood Cells in Vitro

Overview
Specialty Tropical Medicine
Date 1992 May 1
PMID 1599053
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Heparin and various heparin fractions were separated according to differences in molecular weight or affinity for antithrombin III and used for the inhibition of Plasmodium falciparum merozoite invasion of red blood cells in vitro. No variation in sensitivity to heparin was found among the four strains of P. falciparum tested; all required approximately 5 micrograms/ml (0.5 U/ml) of heparin for 50% inhibition of invasion. The most efficient fraction of heparin was the one with low affinity for antithrombin III. Its 50% inhibition concentration was 1 microgram/ml, indicating that it was more efficient than unfractionated heparin and other heparin fractions. The effect of heparin was reversible, since washing of heparin-treated cultures containing mainly schizonts showed no inhibition of merozoite invasion. The results suggest that a heparin fraction with no anticoagulant effect might be useful in the treatment of patients with falciparum malaria.

Citing Articles

SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART).

Maitland K, Hamaluba M, Obonyo N, Oguda E, Mogoka C, Williams T Wellcome Open Res. 2024; 8:484.

PMID: 39219856 PMC: 11362743. DOI: 10.12688/wellcomeopenres.20111.2.


Enhanced virulence of Plasmodium falciparum in blood of diabetic patients.

Chng J, Moll K, Wyss K, Hammar U, Ryden M, Kampe O PLoS One. 2021; 16(6):e0249666.

PMID: 34138868 PMC: 8211161. DOI: 10.1371/journal.pone.0249666.


Parasite histones are toxic to brain endothelium and link blood barrier breakdown and thrombosis in cerebral malaria.

Moxon C, Alhamdi Y, Storm J, Toh J, McGuinness D, Ko J Blood Adv. 2020; 4(13):2851-2864.

PMID: 32579667 PMC: 7362376. DOI: 10.1182/bloodadvances.2019001258.


Polyamidoamine Nanoparticles for the Oral Administration of Antimalarial Drugs.

Marti Coma-Cros E, Biosca A, Marques J, Carol L, Urban P, Berenguer D Pharmaceutics. 2018; 10(4).

PMID: 30423797 PMC: 6321545. DOI: 10.3390/pharmaceutics10040225.


Targeted Phenotypic Screening in and Reveals Novel Modes of Action of Medicines for Malaria Venture Malaria Box Molecules.

Subramanian G, Belekar M, Shukla A, Tong J, Sinha A, Chu T mSphere. 2018; 3(1).

PMID: 29359192 PMC: 5770543. DOI: 10.1128/mSphere.00534-17.